DE0005140008 - Common Stock

Taking everything into account, **DB** scores **3** out of 10 in our fundamental rating. **DB** was compared to 220 industry peers in the **Capital Markets** industry. Both the profitability and financial health of **DB** have multiple concerns. **DB** is not valued too expensively and it also shows a decent growth rate.

In the past year **DB** has reported a negative cash flow from operations.

Of the past 5 years **DB** 4 years were profitable.

The reported operating cash flow has been mixed in the past 5 years: **DB** reported negative operating cash flow in multiple years.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.26% | ||

ROE | 4.73% | ||

ROIC | N/A |

ROA(3y)0.28%

ROA(5y)0.08%

ROE(3y)5.34%

ROE(5y)1.36%

ROIC(3y)N/A

ROIC(5y)N/A

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | 11.96% | ||

GM | N/A |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y192.68%

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

Compared to 1 year ago, **DB** has less shares outstanding

The number of shares outstanding for **DB** has been reduced compared to 5 years ago.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.92 | ||

Debt/FCF | N/A | ||

Altman-Z | N/A |

ROIC/WACCN/A

WACCN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | N/A | ||

Quick Ratio | N/A |

The **Earnings Per Share** has been growing by **29.29%** on average over the past years. This is a very strong growth

Looking at the last year, **DB** shows a small growth in **Revenue**. The Revenue has grown by **2.96%** in the last year.

The **Revenue** has been growing slightly by **2.13%** on average over the past years.

EPS 1Y (TTM)4.43%

EPS 3Y83.25%

EPS 5Y29.29%

EPS Q2Q%40.74%

Revenue 1Y (TTM)2.96%

Revenue growth 3Y5.3%

Revenue growth 5Y2.13%

Sales Q2Q%2.43%

Based on estimates for the next years, **DB** will show a small growth in **Earnings Per Share**. The EPS will grow by **2.07%** on average per year.

The **Revenue** is expected to grow by **2.44%** on average over the next years.

EPS Next Y-10.82%

EPS Next 2Y9.05%

EPS Next 3Y9.72%

EPS Next 5Y2.07%

Revenue Next Year2.42%

Revenue Next 2Y2.88%

Revenue Next 3Y2.77%

Revenue Next 5Y2.44%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

The **Price/Earnings** ratio is **6.51**, which indicates a rather cheap valuation of **DB**.

With a **Price/Forward Earnings** ratio of **5.99**, the valuation of **DB** can be described as very cheap.

Based on the **Price/Forward Earnings** ratio, **DB** is valued cheaper than 93.98% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 6.51 | ||

Fwd PE | 5.99 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | N/A |

PEG (NY)N/A

PEG (5Y)0.22

EPS Next 2Y9.05%

EPS Next 3Y9.72%

Compared to an average industry **Dividend Yield** of **9.19**, **DB** has a dividend in line with its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.8% |

The dividend of **DB** is nicely growing with an annual growth rate of **22.46%**!

The dividend of **DB** decreased in the last 3 years.

Dividend Growth(5Y)22.46%

Div Incr Years2

Div Non Decr Years2

DP25.33%

EPS Next 2Y9.05%

EPS Next 3Y9.72%

**DEUTSCHE BANK AG-REGISTERED**

NYSE:DB (10/14/2024, 8:21:50 PM)

After market: 17.54 +0.09 (+0.52%)**17.45**

**-0.32 (-1.8%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap33.99B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.8% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 6.51 | ||

Fwd PE | 5.99 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.22

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.26% | ||

ROE | 4.73% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | N/A | ||

PM (TTM) | 11.96% | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.02

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.92 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | N/A | ||

Quick Ratio | N/A | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)4.43%

EPS 3Y83.25%

EPS 5Y

EPS Q2Q%

EPS Next Y-10.82%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)2.96%

Revenue growth 3Y5.3%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y